GleanMark

C-MAP CARFILZOMIB MYELOMA ACCESS PROGRAM Trademark

C-MAP CARFILZOMIB MYELOMA ACCESS PROGRAM is a USPTO trademark filed by Onyx Pharmaceuticals, Inc.. Status: Abandoned.

Trademark Facts

MarkC-MAP CARFILZOMIB MYELOMA ACCESS PROGRAM
Serial Number85410049
StatusAbandoned
Filing Date2011-08-29
Mark TypeCombined
Nice Classes044 (Medical Services)
OwnerOnyx Pharmaceuticals, Inc.
Attorney of RecordRichard M. LaBarge
Prosecution Events36
Latest EventMAB6 on 2014-04-21

Goods & Services

"CARFILZOMIB MYELOMA ACCESS PROGRAM"

Related